Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non‐opsonic epitopes
Open Access
- 14 November 2005
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 59 (1) , 20-30
- https://doi.org/10.1111/j.1365-2958.2005.04913.x
Abstract
Summary: Antibodies directed against a pathogenic microorganism may recognize either protective or non‐protective epitopes. Because antibodies elicited by a vaccine must be directed against protective epitopes, it is essential to understand the molecular properties that distinguish the two types of epitope. Here we analyse this problem for the antiphagocytic M protein of Streptococcus pyogenes, using the opsonizing capacity of antibodies to estimate their ability to confer protection in vivo. Our studies were focused on the M5 protein, which has three surface‐exposed regions: the amino‐terminal hypervariable region (HVR) and the B‐ and C‐repeat regions. We first analysed the role of different M5 regions in phagocytosis resistance under non‐immune conditions, employing chromosomal mutants expressing M5 proteins with internal deletions, and demonstrate that only the B‐repeat region is essential for phagocytosis resistance. However, only antibodies to the HVR were opsonic. This apparent paradox could be explained by the ability of fibrinogen and albumin to specifically bind to the B‐ and C‐repeats, respectively, causing inhibition of antibody binding under physiological conditions, while antibodies to the HVR could bind and promote deposition of complement. These data indicate that binding of human plasma proteins plays an important role in determining the location of opsonic and non‐opsonic epitopes in streptococcal M protein.Keywords
This publication has 52 references indexed in Scilit:
- Engagement of CD46 and α5β1 integrin by group A streptococci is required for efficient invasion of epithelial cellsCellular Microbiology, 2005
- Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathwayMolecular Microbiology, 2005
- Extension of the Lancefield Classification for Group A Streptococci by Addition of 22 New M Protein Gene Sequence Types from Clinical Isolates: emm103 to emm124Clinical Infectious Diseases, 2002
- Deceptive imprinting: a cosmopolitan strategy for complicating vaccinationVaccine, 1998
- Role of the conserved C‐repeat region of the M protein of Streptococcus pyogenesMolecular Microbiology, 1995
- Binding properties of protein Arp, A bacterial IgA-receptorMolecular Immunology, 1991
- Common protective antigens of group A streptococcal M proteins masked by fibrinogen.The Journal of Experimental Medicine, 1984
- Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein.The Journal of Experimental Medicine, 1983
- THE ENHANCEMENT OF BACTERIAL PHAGOCYTOSIS BY SERUMThe Journal of Experimental Medicine, 1969
- DIFFERENTIATION OF GROUP A STREPTOCOCCI WITH A COMMON R ANTIGEN INTO THREE SEROLOGICAL TYPES, WITH SPECIAL REFERENCE TO THE BACTERICIDAL TESTThe Journal of Experimental Medicine, 1957